IDEAS home Printed from https://ideas.repec.org/a/sae/evarev/v31y2007i4p401-412.html
   My bibliography  Save this article

When Do Simpler Sexual Behavior Data Collection Techniques Suffice?

Author

Listed:
  • Steven D. Pinkerton

    (Medical College of Wisconsin)

  • Eric G. Benotsch

    (University of Colorado at Denver & Health Sciences Center)

  • John Mikytuck

    (AIDS Help, Inc.)

Abstract

The “gold standard†for evaluating human immunodeficiency virus (HIV) prevention programs is a partner-by-partner sexual behavior assessment that elicits information about each sex partner and the activities engaged in with that partner. When collection of detailed partner-by-partner data is not feasible, aggregate data (e.g., total numbers of partners and acts of various types) must suffice. Lack of specificity in the primary data often translates into uncertainty in modeled outcomes, such as participants' risk of HIV acquisition. To our knowledge, no previous study has attempted to quantify this uncertainty. The results of the present analysis of the risk of HIV acquisition by men vacationing in Key West indicate that the use of aggregate rather than partner-by-partner data introduced relatively little uncertainty into the HIV risk estimates. Collection of aggregate data is a viable alternative to detailed partner-by-partner data, at least in some circumstances.

Suggested Citation

  • Steven D. Pinkerton & Eric G. Benotsch & John Mikytuck, 2007. "When Do Simpler Sexual Behavior Data Collection Techniques Suffice?," Evaluation Review, , vol. 31(4), pages 401-412, August.
  • Handle: RePEc:sae:evarev:v:31:y:2007:i:4:p:401-412
    DOI: 10.1177/0193841X07300237
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0193841X07300237
    Download Restriction: no

    File URL: https://libkey.io/10.1177/0193841X07300237?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Holmberg, S.D., 1996. "The estimated prevalence and incidence of HIV in 96 large US metropolitan areas," American Journal of Public Health, American Public Health Association, vol. 86(5), pages 642-654.
    2. William Hildred & Larry Watkins, 1996. "The Nearly Good, the Bad, and the Ugly in Cost-Effectiveness Analysis of Health Care," Journal of Economic Issues, Taylor & Francis Journals, vol. 30(3), pages 755-775, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. A. David Paltiel & Harold A. Pollack, 2010. "Price, Performance, and the FDA Approval Process: The Example of Home HIV Testing," Medical Decision Making, , vol. 30(2), pages 217-223, March.
    2. Wilson, Amy R. & Kahn, James G., 2003. "Preventing HIV in injection drug users: exploring the tradeoffs between interventions," Socio-Economic Planning Sciences, Elsevier, vol. 37(4), pages 269-288, December.
    3. Kuchler, Fred & Golan, Elise H., 1999. "Assigning Values To Life: Comparing Methods For Valuing Health Risks," Agricultural Economic Reports 34037, United States Department of Agriculture, Economic Research Service.
    4. Ana P. Johnson-Masotti & Purushottam W. Laud & Raymond G. Hoffmann & Matthew J. Hayat & Steven D. Pinkerton, 2004. "A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention," Medical Decision Making, , vol. 24(6), pages 634-653, November.
    5. Georgiy Bobashev & Sarah Mars & Nicholas Murphy & Clinton Dreisbach & William Zule & Daniel Ciccarone, 2019. "Heroin type, injecting behavior, and HIV transmission. A simulation model of HIV incidence and prevalence," PLOS ONE, Public Library of Science, vol. 14(12), pages 1-17, December.
    6. Lessner, Lawrence, 2008. "HIV prevalence for New York State using Newborn Seroprevalence and AIDS Surveillance Data," Socio-Economic Planning Sciences, Elsevier, vol. 42(4), pages 286-299, December.
    7. Schilling, Robert F. & Fontdevila, Jorge & Fernando, Daniel & El-Bassel, Nabila & Monterroso, Edgar, 2004. "Proximity to needle exchange programs and HIV-related risk behavior among injection drug users in Harlem," Evaluation and Program Planning, Elsevier, vol. 27(1), pages 25-33, February.
    8. Iguchi, Martin Y. & Bux, Donald A. & Kushner, Harvey & Lidz, Victor, 2001. "Correlates of HIV risk among female sex partners of injecting drug users in a high-seroprevalence area," Evaluation and Program Planning, Elsevier, vol. 24(2), pages 175-185, May.
    9. Amy Lansky & Teresa Finlayson & Christopher Johnson & Deborah Holtzman & Cyprian Wejnert & Andrew Mitsch & Deborah Gust & Robert Chen & Yuko Mizuno & Nicole Crepaz, 2014. "Estimating the Number of Persons Who Inject Drugs in the United States by Meta-Analysis to Calculate National Rates of HIV and Hepatitis C Virus Infections," PLOS ONE, Public Library of Science, vol. 9(5), pages 1-9, May.
    10. Wilson, Amy R. & Kahn, James G. & Oren, Shmuel S., 2005. "Targeting interventions to high-risk populations: Benefits and costs," Socio-Economic Planning Sciences, Elsevier, vol. 39(4), pages 335-349, December.
    11. Barton H. Hamilton & Andrés Hincapié & Robert A. Miller & Nicholas W. Papageorge, 2021. "Innovation And Diffusion Of Medical Treatment," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 62(3), pages 953-1009, August.
    12. Steven D. Pinkerton & David R. Holtgrave & Laura C. Leviton & David A. Wagstaff & Paul R. Abramson, 1998. "Model-Based Evaluation of Hiv Prevention Interventions," Evaluation Review, , vol. 22(2), pages 155-174, April.
    13. Ana P. Johnson-Masotti & Purushottam W. Laud & Raymond G. Hoffmann & Matthew J. Hayat & Steven D. Pinkerton, 2001. "Probabilistic Cost-Effectiveness Analysis of HIV Prevention," Evaluation Review, , vol. 25(4), pages 474-502, August.
    14. Schilling, Robert F. & Fernando, Daniel & Fontdevila, Jorge & El-Bassel, Nabila, 2000. "HIV risk reduction among injection drug users: explaining the lack of anticipated outcomes in a community-level controlled comparison study," Evaluation and Program Planning, Elsevier, vol. 23(3), pages 301-313, August.
    15. Jonathan P. Caulkins & Edward H. Kaplan & Peter Lurie & Thomas O'Connor & Sung-Ho Ahn, 1998. "Can Difficult-to-Reuse Syringes Reduce the Spread of HIV Among Injection Drug Users?," Interfaces, INFORMS, vol. 28(3), pages 23-33, June.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:evarev:v:31:y:2007:i:4:p:401-412. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.